We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current ACHL market cap is 39.73M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.21M | 2.39M | 1.39M | 2M | 1.43M |
| Operating Income | -15.7M | -16.09M | -17.53M | -11.58M | -19.38M |
| Net Income | -16.85M | -16.68M | -18.63M | -12.27M | -16.38M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 531k | 3.13M | 7.32M | 6.08M |
| Operating Income | -13.76M | -33.2M | -61.06M | -71.13M | -66.78M |
| Net Income | -13.99M | -33.2M | -61.1M | -71.18M | -69.67M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 197.91M | 175.34M | 161.46M | 145.74M | 131.19M |
| Total Liabilities | 24.06M | 21.85M | 19.09M | 15.39M | 15.71M |
| Total Equity | 173.84M | 153.49M | 142.37M | 130.35M | 115.48M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 105.21M | 218.92M | 317.11M | 220.36M | 161.46M |
| Total Liabilities | 3.86M | 29.55M | 27.58M | 23.31M | 19.09M |
| Total Equity | 101.35M | 189.37M | 289.53M | 197.04M | 142.37M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -35.26M | -34.26M | -48.45M | -17.51M | N/A |
| Investing | -991k | -1.05M | -1.1M | -695k | N/A |
| Financing | 1,000 | 9k | 9k | 5k | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -14.14M | -25.25M | -59.28M | -59.54M | -48.45M |
| Investing | -942k | -11.85M | -7.63M | -7.51M | -1.1M |
| Financing | 93.62M | 113.7M | 160.76M | 1,000 | 9k |
| Market Cap | 39.73M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 41.08M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.06 (6.12%) |
| Company Name | Achilles Therapeutics PLC |
| Address |
245 hammersmith road london W6 8PW |
| Website | https://www.achillestx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
